Lydian
Lydian Raises $43M Series A for Synthetic Aviation Fuel Production
Lydian announced $43M in Series A financing on July 30, 2026. Lydian raised a $43 million Series A led by Breakthrough Energy Ventures to support the launch of its PIVOT platform for synthetic aviation fuel production.
Round details
The financing includes backing from Breakthrough Energy Ventures, AP Ventures, Builders Vision, Congruent Ventures, Galvanize, Grok Ventures, Union Square Ventures, Voyager Ventures. The company did not publish a valuation with the announcement.
- Round: Series A
- Capital announced: $43M
How the company plans to use the capital
The financing supports the launch of PIVOT, Lydian’s full-stack production platform, which the company said enables developers to build and operate synthetic fuel facilities at lower cost and gives customers a direct path to buy fuel from Lydian’s own projects. The announcement did not specify a detailed use of proceeds beyond this.
Why this matters for GTM teams
According to the announcement, the round is the first announced deployment from Breakthrough Energy Ventures’ oneworld BEV Fund, a strategic investment fund supported by global airlines and members of the aviation industry, and it includes continued support from existing investors.
Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.
Source and methodology
This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.
Primary source: Lydian Series A announcement.
Company Info
Investors (8)
Share
Related Reports
Wabi Raises $55M at $1.25B Valuation in IVP-Led Funding
Wabi announced $55 million in funding led by IVP at a $1.25 billion valuation, which it said will support continued product development and expansion.
StimCardio Raises $30M Series A for Wearable AF Therapeutic
StimCardio announced the closing of an oversubscribed $30 million Series A led by Metis Medtech, expected to fund the company through its planned NeuroPulse 2 pivotal study and preparation for an FDA De Novo submission.
Casap Raises $56M Series B for AI Agents in Financial Services
Casap raised a $56 million Series B led by Base10 Partners, with Experian and Synchrony participating, to advance its AI agent platform for financial services.
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started


